Human	O
cytomegalovirus	O
elevates	O
levels	O
of	O
the	O
cellular	B-Cell
protein	O
p53	O
in	O
infected	O
fibroblasts	B-Cell
.	O

Human	O
cytomegalovirus	O
(	O
HCMV	O
)	O
,	O
like	O
other	O
DNA	O
tumor	B-Cancer
viruses	O
,	O
induces	O
morphological	O
transformation	O
of	O
cells	B-Cell
in	O
vitro	O
and	O
stimulates	O
host	O
cell	B-Cell
macromolecular	O
synthesis	O
in	O
infected	O
cells	B-Cell
.	O

Since	O
other	O
DNA	O
tumor	B-Cancer
viruses	O
,	O
such	O
as	O
simian	O
virus	O
40	O
and	O
adenovirus	O
,	O
have	O
previously	O
been	O
shown	O
to	O
interact	O
with	O
cellular	B-Cell
protein	O
p53	O
,	O
we	O
investigated	O
whether	O
infection	O
of	O
cells	B-Cell
by	O
HCMV	O
would	O
modulate	O
cellular	B-Cell
p53	O
levels	O
.	O

Our	O
results	O
indicate	O
that	O
HCMV	O
elevates	O
cellular	B-Cell
p53	O
levels	O
on	O
the	O
order	O
of	O
10	O
-	O
to	O
20	O
-	O
fold	O
in	O
infected	O
fibroblasts	B-Cell
.	O

The	O
induction	O
of	O
elevated	O
p53	O
levels	O
was	O
dependent	O
upon	O
the	O
presence	O
of	O
active	O
virus	O
and	O
was	O
prevented	O
by	O
neutralizing	O
antibody	O
.	O

The	O
induction	O
of	O
elevated	O
p53	O
levels	O
was	O
determined	O
not	O
to	O
be	O
due	O
to	O
virus	O
-	O
receptor	O
interactions	O
or	O
HCMV	O
late	O
events	O
.	O

The	O
induction	O
of	O
elevated	O
p53	O
levels	O
commenced	O
at	O
immediate	O
-	O
early	O
times	O
of	O
the	O
HCMV	O
multiplication	O
cycle	O
(	O
6	O
h	O
postinfection	O
)	O
and	O
reached	O
maximal	O
levels	O
by	O
24	O
h	O
postinfection	O
,	O
before	O
most	O
of	O
the	O
HCMV	O
DNA	O
synthesis	O
was	O
initiated	O
.	O

HCMV	O
immediate	O
-	O
early	O
proteins	O
were	O
clearly	O
shown	O
to	O
be	O
responsible	O
for	O
elevating	O
p53	O
levels	O
in	O
infected	O
fibroblasts	B-Cell
;	O
expression	O
of	O
HCMV	O
immediate	O
-	O
early	O
region	O
1	O
and	O
2	O
proteins	O
resulted	O
in	O
elevation	O
of	O
p53	O
levels	O
in	O
transfected	O
human	O
fibroblasts	B-Cell
.	O

This	O
is	O
the	O
first	O
report	O
of	O
increased	O
p53	O
levels	O
caused	O
by	O
HCMV	O
in	O
infected	O
fibroblasts	B-Cell
.	O

